Drugmaker reverses course, plans to seek FDA approval for Alzheimer's treatment

WITI Fox Milwaukee

Oct 22, 2019

In an unexpected reversal, pharmaceutical giant Biogen said it will pursue US Food and Drug Administration approval for aducanumab, an experimental treatment for early Alzheimer's…